Bioasis Technologies

Bioasis Technologies ROA

The Return on Assets (ROA) of Bioasis Technologies (BIOAF) as of Oct 24, 2026 is -130.64 %. In the previous year, Return on Assets (ROA) was 21.32 % — a change of -712.84% (lower).

ROA

-130.64 %

YoY

-712.84%

Last updated:

In 2022, Bioasis Technologies's return on assets (ROA) was -130.64 %, a -712.84% increase from the 21.32 % ROA in the previous year.

The Bioasis Technologies ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2015
-128.24 CAD
Jan 1, 2016
-119.51 CAD
Jan 1, 2017
-269.21 CAD
Jan 1, 2018
-434.43 CAD
Jan 1, 2019
-199.25 CAD
Jan 1, 2020
-430.71 CAD
Jan 1, 2021
21.32 CAD
Jan 1, 2022
-130.64 CAD
The Bioasis Technologies ROA history
YEARROAYoY
-130.64 %-712.84%
21.32 %-104.95%
-430.71 %+116.17%
-199.25 %-54.14%
-434.43 %+61.37%
-269.21 %+125.27%
-119.51 %-6.81%
-128.24 %-8.40%
-140.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioasis Technologies Stock analysis

What does Bioasis Technologies do? biOasis Technologies, Inc. generates revenue by developing therapeutics using its proprietary xB3 platform, which is designed to deliver treatments across the blood brain barrier for central nervous system disorders. The company focuses on areas of high unmet medical need, specifically targeting brain cancers and neurodegenerative diseases. This technology leverages a human transport protein found circulating at low levels in the blood to shuttle molecules to their targets within the brain via receptor-mediated transcytosis. The firm markets its in-house development programs aimed at creating both symptomatic and disease-modifying treatments for brain-related diseases and disorders. By utilizing the xB3 platform, biOasis Technologies, Inc. addresses specific therapeutic challenges in the central nervous system, offering solutions for conditions that currently lack adequate medical interventions. The business model relies on the efficacy of this delivery system to reach targets within the brain, serving the needs of patients suffering from these severe neurological conditions. Bioasis Technologies is one of the most popular companies on Eulerpool.

ROA Details

Understanding Bioasis Technologies's Return on Assets (ROA)

Bioasis Technologies's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Bioasis Technologies's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Bioasis Technologies's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Bioasis Technologies’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Bioasis Technologies stock

Return on Assets (ROA) of Bioasis Technologies is -130.64 % in 2022.

Return on Assets (ROA) of Bioasis Technologies changed from 21.32 % to -130.64 %, representing a -712.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Bioasis Technologies since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Bioasis Technologies with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Bioasis Technologies

All Key Metrics — Bioasis Technologies